Patients with ankylosing spondylitis have high risk of irritable bowel syndrome: a long-term nationwide population-based cohort study

References

• Bibbo S, Ianiro G, Giorgio V, et al. The role of diet on gut microbiota composition. Eur Rev Med Pharmacol Sci. 2016;20(22):4742–4749.
   PubMed Web of Science ®Google Scholar
• Kashtanova DA, Popenko AS, Tkacheva ON, et al. Association between the gut microbiota and diet: fetal life, early childhood, and further life. Nutrition. 2016;32(6):620–627.
   PubMed Web of Science ®Google Scholar
• Jin Y, Wu S, Zeng Z, et al. Effects of environmental pollutants on gut microbiota. Environ Pollut. 2017;222:1–9.
   PubMed Web of Science ®Google Scholar
• Purchiaroni F, Tortora A, Gabrielli M, et al. The role of intestinal microbiota and the immune system. Eur Rev Med Pharmacol Sci. 2013;17(3):323–333.
   PubMed Web of Science ®Google Scholar
• Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121–141.
   PubMed Web of Science ®Google Scholar
• Zhuang X, Xiong L, Li L, et al. Alterations of gut microbiota in patients with irritable bowel syndrome: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2017;32(1):28–38.
   PubMed Web of Science ®Google Scholar
• Rodiño-Janeiro BK, Vicario M, Alonso-Cotoner C, et al. A review of microbiota and irritable bowel syndrome: future in therapies. Adv Ther. 2018;35(3):289–310.
   PubMed Web of Science ®Google Scholar
• Munoz-Garach A, Diaz-Perdigones C, Tinahones FJ. Gut microbiota and type 2 diabetes mellitus. Endocrinol Nutr. 2016;63(10):560–568.
   PubMedGoogle Scholar
• Candon S, Perez-Arroyo A, Marquet C, et al. Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes. PLOS ONE. 2015;10(5):e0125448.
   PubMed Web of Science ®Google Scholar
• Vieira SM, Pagovich OE, Kriegel MA. Diet, microbiota and autoimmune diseases. Lupus. 2014;23(6):518–526.
   PubMed Web of Science ®Google Scholar
• Fung TC, Olson CA, Hsiao EY. Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci. 2017;20(2):145–155.
   PubMed Web of Science ®Google Scholar
• Marizzoni M, Provasi S, Cattaneo A, et al. Microbiota and neurodegenerative diseases. Curr Opin Neurol. 2017;30(6):630–638.
   PubMed Web of Science ®Google Scholar
• Rashid T, Ebringer A, Wilson C. The link between klebsiella and ankylosing spondylitis in worldwide geographical locations. Curr Rheumatol Rev. 2016;12(3):223–231.
   PubMedGoogle Scholar
• Wang S, Chen Z, Hu L, et al. Increased risk of inflammatory bowel disease among patients with ankylosing spondylitis: a 13-year population-based cohort study. Front Immunol. 2020;11:11.
   PubMed Web of Science ®Google Scholar
• Bhattarai Y, Muniz Pedrogo DA, Kashyap PC. Irritable bowel syndrome: a gut microbiota-related disorder? Am J Physiol Gastrointest Liver Physiol. 2017;312(1):G52–g62.
   PubMed Web of Science ®Google Scholar
• Raskov H, Burcharth J, Pommergaard H-C, et al. Irritable bowel syndrome, the microbiota and the gut-brain axis. Gut Microbes. 2016;7(5):365–383.
   PubMed Web of Science ®Google Scholar
• Ohman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol. 2010;7(3):163–173.
   PubMed Web of Science ®Google Scholar
• Koloski N, Jones M, Walker MM, et al. Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress. Aliment Pharmacol Ther. 2019;49(5):546–555.
   PubMed Web of Science ®Google Scholar
• Wallman JK, Mogard E, Marsal J, et al. Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity? Ann Rheum Dis. 2020;79(1):159–161.
   PubMed Web of Science ®Google Scholar
• Ford AC, Talley NJ, Walker MM, et al. Increased prevalence of autoimmune diseases in functional gastrointestinal disorders: case-control study of 23471 primary care patients. Aliment Pharmacol Ther. 2014;40(7):827–834.
   PubMed Web of Science ®Google Scholar
• Rezaie A, Pimentel M, Cohen E. Autoimmunity as a potential cause of post-infectious gut dysmotility: a longitudinal observation. Am J Gastroenterol. 2017;112(4):656–657.
   PubMed Web of Science ®Google Scholar
• Klingberg E, Magnusson MK, Strid H, et al. A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin. Arthritis Res Ther. 2019;21(1):248.
   PubMed Web of Science ®Google Scholar
• Wu JJ, Penfold RB, Primatesta P, et al. The risk of depression, suicidal ideation and suicide attempt in patients with psoriasis, psoriatic arthritis or ankylosing spondylitis. J Eur Acad Dermatol Venereol. 2017;31(7):1168–1175.
   PubMed Web of Science ®Google Scholar
• Pellissier S, Bonaz B. The place of stress and emotions in the irritable bowel syndrome. Vol. 103. Cambridge, Massachusetts: Vitam Horm; 2017. p. 327–354.
   Google Scholar
• Chen B, Li J, He C, et al. Role of HLA-B27 in the pathogenesis of ankylosing spondylitis (review). Mol Med Rep. 2017;15(4):1943–1951.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang YJ, Chen J, et al. The association of HLA-B27 and Klebsiella pneumoniae in ankylosing spondylitis: a systematic review. Vol. 117. Cambridge, Massachusetts: Microb Pathog; 2018. p. 49–54.
   Google Scholar
• Asquith M, Sternes PR, Costello M-E, et al. HLA alleles associated with risk of ankylosing spondylitis and rheumatoid arthritis influence the gut microbiome. Arthritis Rheumatol. 2019;71(10):1642–1650.
   PubMed Web of Science ®Google Scholar
• Sabo CM, and Dumitrascu DL. Microbiota and the irritable bowel syndrome. C.so Bramante: Minerva Gastroenterol (Torino); 2021.
   Google Scholar
• Ganji L, Alebouyeh M, Shirazi MH, et al. Dysbiosis of fecal microbiota and high frequency of citrobacter, klebsiella spp., and actinomycetes in patients with irritable bowel syndrome and gastroenteritis. Gastroenterol Hepatol Bed Bench. 2016;9(4):325–330.
   PubMedGoogle Scholar
• Youn YH, Kim HC, Lim HC, et al. Long-term clinical course of post-infectious irritable bowel syndrome after shigellosis: a 10-year follow-up study. J Neurogastroenterol Motil. 2016;22(3):490–496.
   PubMed Web of Science ®Google Scholar
• Distrutti E, Monaldi L, Ricci P, et al. Gut microbiota role in irritable bowel syndrome: new therapeutic strategies. World J Gastroenterol. 2016;22(7):2219–2241.
   PubMed Web of Science ®Google Scholar
• Simrén M, Barbara G, Flint HJ, et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut. 2013;62(1):159–176.
   PubMed Web of Science ®Google Scholar
• Wright C, Sibani S, Trudgian D, et al. Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays. Mol Cell Proteomics. 2012;11(2):M9.00384.
   Web of Science ®Google Scholar
• Quaden DH, De Winter LM, Somers V. Detection of novel diagnostic antibodies in ankylosing spondylitis: an overview. Autoimmun Rev. 2016;15(8):820–832.
   PubMed Web of Science ®Google Scholar
• Hu Q, Sun Y, Li Y, et al. Anti-SIRT1 autoantibody is elevated in ankylosing spondylitis: a potential disease biomarker. BMC Immunol. 2018;19(1):38.
   PubMed Web of Science ®Google Scholar
• Wellman AS, Metukuri MR, Kazgan N, et al. intestinal epithelial sirtuin 1 regulates intestinal inflammation during aging in mice by altering the intestinal microbiota. Gastroenterology. 2017;153(3):772–786.
   PubMed Web of Science ®Google Scholar
• Ren MT, Gu M-L, Zhou -X-X, et al. Sirtuin 1 alleviates endoplasmic reticulum stress-mediated apoptosis of intestinal epithelial cells in ulcerative colitis. World J Gastroenterol. 2019;25(38):5800–5813.
   PubMed Web of Science ®Google Scholar
• Wood JD, Liu S, Drossman DA, et al. Anti-enteric neuronal antibodies and the irritable bowel syndrome. J Neurogastroenterol Motil. 2012;18(1):78–85.
   PubMed Web of Science ®Google Scholar
• Taurog JD, Chhabra A, Colbert RA. Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med. 2016;374(26):2563–2574.
   PubMed Web of Science ®Google Scholar
• Ford AC, Lacy BE, Talley NJ. Irritable bowel syndrome. N Engl J Med. 2017;376(26):2566–2578.
   PubMed Web of Science ®Google Scholar
• Singh N, Yadav H, Marotta F, et al. PROBIOTICS - A PROBABLE THERAPEUTIC AGENT FOR SPONDYLOARTHROPATHY. Int J Probiotics Prebiotics. 2017;12(2):57–68.
   PubMedGoogle Scholar
• Didari T, Mozaffari S, Nikfar S, et al. Effectiveness of probiotics in irritable bowel syndrome: updated systematic review with meta-analysis. World J Gastroenterol. 2015;21(10):3072–3084.
   PubMed Web of Science ®Google Scholar
• Francavilla R, Piccolo M, Francavilla A, et al. Clinical and microbiological effect of a multispecies probiotic supplementation in celiac patients with persistent ibs-type symptoms: a randomized, double-blind, placebo-controlled, multicenter trial. J Clin Gastroenterol. 2019;53(3):e117–e125.
   PubMed Web of Science ®Google Scholar
• Erdrich S, Hawrelak JA, Myers SP, et al. A systematic review of the association between fibromyalgia and functional gastrointestinal disorders. Therap Adv Gastroenterol. 2020;13:1756284820977402.
   Web of Science ®Google Scholar